載入中
NYSEHealthcareMedical - Diagnostics & Research
最新資料
US$262.21
+US$2.33 · +0.90%
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
前收盤價
US$262.21
+US$2.33 · +0.90%
盤後
US$264.1
+US$1.89 · +0.72%
10月12日 下午5:46 ET
盤中時間採用ET。市場資料可能有所延遲。
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
日內區間
目前US$262.21
52週區間
目前US$262.21
盤中時間採用ET。市場資料可能有所延遲。
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
日內區間
目前US$262.21
52週區間
目前US$262.21
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 163.1億 USD | 154.05億 USD | 149.84億 USD | 144.1億 USD | 138.74億 USD |
| 銷貨成本 | 108.8億 USD | 100.3億 USD | 97.45億 USD | 93.82億 USD | 92.33億 USD |
| 毛利 | 54.3億 USD | 53.75億 USD | 52.39億 USD | 50.28億 USD | 46.41億 USD |
| 銷售、一般及管理費用 | 19.88億 USD | 19.92億 USD | 20.53億 USD | 20.71億 USD | 19.64億 USD |
| 營業費用 | 32.48億 USD | 31.73億 USD | 32.62億 USD | 32.29億 USD | 32.48億 USD |
| 利息收入 | 4500萬 USD | 4700萬 USD | 3600萬 USD | 1300萬 USD | 600萬 USD |
| 利息支出 | 7.29億 USD | 6.7億 USD | 6.72億 USD | 4.16億 USD | 3.75億 USD |
| 折舊和攤銷 | 6.4億 USD | 11.14億 USD | 11.25億 USD | 11.3億 USD | 12.64億 USD |
| 營業利益 | 21.82億 USD | 22.02億 USD | 19.77億 USD | 17.99億 USD | 13.93億 USD |
| 淨利 | 13.6億 USD | 13.73億 USD | 13.58億 USD | 10.91億 USD | 9.66億 USD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$282.8
上漲空間 7.85%報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T821.48億0.06%130.34兆 JPY0.09%¥122,950+0.08%
Vanguard Morningstar Total Stock Market ETFVTI13.86億0.06%2.3兆 USD0.03%US$381.57-0.10%
Vanguard S&P 500 ETFVOO11.57億0.07%1.8兆 USD0.03%US$715.13-0.06%
Vanguard Morningstar Mid-Cap ETFVO9.43億0.42%2264億 USD0.03%US$80.92-0.27%
iShares Core S&P 500 ETFIVV5.69億0.06%8964.4億 USD0.03%US$781.44-0.07%
State Street SPDR S&P 500 ETFSPY5.18億0.06%8216.79億 USD0.09%US$778.1-0.06%
Vanguard Morningstar Value ETFVTV4.17億0.16%2624億 USD0.03%US$221.43+0.38%
State Street Health Care Select Sector SPDR ETFXLV3億0.69%443.1億 USD0.08%US$171.99+0.69%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Mid-Cap ETFVOiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVState Street Health Care Select Sector SPDR ETFXLVAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
